HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 29/2/273    most recent 09031936.00000106v1 Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ho, J. C. Articles by Lam, W. K. Search for Related Content PubMed PubMed Citation Articles by Ho, J. C. Articles by Lam, W. K.

Disturbance of systemic antioxidant profile in nonsmall cell lung carcinoma

University Depts of ¹ Medicine, ² Diagnostic Radiology, and ³ Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China.

CORRESPONDENCE: J. C. Ho, Division of Respiratory and Critical Care Medicine, University Dept of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China. Fax: 852 28555411. E-mail: jcmho{at}netvigator.com

Keywords: Catalase, glutathione peroxidase, lung cancer, superoxide dismutase

Received: January 1, 2006
Accepted September 14, 2006

The present study aimed to determine the alterations of antioxidant activities in erythrocytes from patients with nonsmall cell lung carcinoma (NSCLC).

A comparative study of the systemic antioxidant activities in red blood cell lysate from subjects with NSCLC and healthy control subjects was conducted. The antioxidants catalase, superoxide dismutase (SOD) and glutathione peroxidase (GPx) were measured using chemical kinetic reactions under spectrophotometry.

In total, 189 cases of mostly advanced-stage IIIB or stage IV NSCLC and 202 healthy controls were studied. In subjects with lung cancer, there was similar catalase activity, lower SOD activity (median (interquartile range) 13.4 (9.0–27.2) versus 48.7 (27.0–64.3) U·(ghaemoglobulin(Hb)^-1), and higher GPx activity (175.2 (126.6–288.3) versus 49.2 (39.5–59.2) mU·(gHb)^-1) compared with controls. The antioxidant activities in lung cancer subjects were not associated with age, sex, smoking status, or tumour cell types. However, more advanced disease (stage IV compared with stage IIIB) was associated with lower SOD activity. Using multivariable analysis, the presence of lung cancer independently predicted SOD and GPx activities.

In conclusion, nonsmall cell lung carcinoma in Chinese subjects is associated with alterations in systemic antioxidant activities, which may play an important role in carcinogenesis.